DR. SCOTT R FLOYD, MD
Radiology in Boston, MA
License number
Massachusetts 219503
Category
Radiology
Type
Radiation Oncology
Address
Address
330 Brookline Ave Beth Israel Deaconess Medical Center-Radiation, Boston, MA 02215
Phone
(617) 667-2345
(617) 667-4990 (Fax)
(617) 667-4990 (Fax)
Personal information
See more information about SCOTT R FLOYD at radaris.comName
Address
Phone
228 La Grange Pl, West Roxbury, MA 02132
Professional information
See more information about SCOTT R FLOYD at trustoria.com
Dr. Scott R Floyd, Boston MA - MD (Doctor of Medicine)
Dr. Scott R Floyd, Boston MA - MD (Doctor of Medicine)
Specialties:
Radiation Oncology
Address:
Harbor Med Prac Radiation Onc
330 Brookline Ave SUITE FNB25, Boston 02215
(617) 667-2345 (Phone)
330 Brookline Ave SUITE FNB25, Boston 02215
(617) 667-2345 (Phone)
Certifications:
Radiation Oncology, 2009
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Harbor Med Prac Radiation Onc
330 Brookline Ave SUITE FNB25, Boston 02215
Beth Israel Deaconess Medical Center
330 Brookline Ave, Boston 02215
330 Brookline Ave SUITE FNB25, Boston 02215
Beth Israel Deaconess Medical Center
330 Brookline Ave, Boston 02215
Education:
Medical School
Yale University
Graduated: 2000
Hospital Of Saint Raphael
Harvard Radiation Oncology Program
Yale University
Graduated: 2000
Hospital Of Saint Raphael
Harvard Radiation Oncology Program
Scott R Floyd, Boston MA
Scott R Floyd, Boston MA
Specialties:
Internal Medicine, Medical Oncology, Radiation Oncology
Work:
Radation Oncology HMFP Bidmc
330 Brookline Ave, Boston, MA 02215
330 Brookline Ave, Boston, MA 02215
Education:
Yale University (2002)
Compositions And Methods For Modulating Brd4 Bioactivity
Compositions And Methods For Modulating Brd4 Bioactivity
US Patent:
2014004, Feb 13, 2014
Filed:
Jul 18, 2013
Appl. No.:
13/945674
Inventors:
Scott R. Floyd - West Roxbury MA, US
International Classification:
A61K 38/46, C12Q 1/68, G01N 33/573
US Classification:
424445, 424 946, 514 44 R, 424490, 424400, 424443, 435375, 435 74, 435 612, 506 9, 435 611
Abstract:
Compositions and methods for increasing or decreasing DNA repair are provided. Composition includes a Brd4 polypeptide, fragment, fusion, or variant thereof. The fusion protein can include a protein transduction, a targeting domain, or a combination thereof to enhance delivery of the fusion protein to the interior of a particular target cell, such as a cancer cell. Inhibitory nucleic acids that target a Brd4 mRNA and antibodies that target a Brd4 polypeptide are also disclosed. The inhibitory nucleic acid or antibody can target a sequence or epitope on Brd4 isoform B that is absent on Brd4 isoform A and Brd4 isoform C. Methods for increasing or decreasing the sensitivity of cells to a DNA damaging agent, methods of treating cancer, and methods of determining cells' sensitivity to a DNA damaging agent are also disclosed.